T

Tizona Therapeutics, Inc.

48 employees

Tizona develops next-generation immunotherapies

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical
Immune-Oncology Therapeutics

Date founded

2015

Funding rounds raised

Total raised

$300M

from 10 investors over 10 rounds

T

Tizona Therapeutics, Inc. raised $300M on July 21, 2020

Investors: Gilead Sciences

T

Tizona Therapeutics, Inc. raised $43M on March 8, 2016

Investors: Astellas Venture Capital L.L.C., Abingworth, Lightstone Ventures, MPM Capital, Canaan and InterWest Partners

T

Tizona Therapeutics, Inc. raised $27M on January 10, 2016

Investors: Astellas Venture Capital L.L.C., MPM Capital and InterWest Partners

FAQ